HoliStick, a France-based surgical device spinout exploiting research from multiple institutions, made its public debut on Thursday with an undisclosed sum of cash from VC firm Truffle Capital.
Harvard University’s tech transfer arm, Office of Technology Development, has granted HoliStick a licence to commercialise technology co-owned by Harvard, Massachusetts Institute of Technology (MIT), Brigham & Women’s Hospital and Boston Children’s Hospital.
The company is working on a catheter device that would make it easier for surgeons to conduct operations on…
